Izotropic (OTCMKTS:IZOZF) Announces Earnings Results, Misses Expectations By $0.02 EPS

Izotropic (OTCMKTS:IZOZF) announced its quarterly earnings results on Monday. The company reported ($0.01) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02), Zacks reports.

Izotropic Stock Performance

OTCMKTS IZOZF traded up $0.01 during trading hours on Monday, reaching $0.14. The company’s stock had a trading volume of 12,386 shares, compared to its average volume of 22,122. The business has a 50-day simple moving average of $0.17 and a 200 day simple moving average of $0.18. Izotropic has a 52 week low of $0.10 and a 52 week high of $0.37.

Izotropic Company Profile

Izotropic Corporation is a medical technology company focused on developing advanced breast-imaging systems. Its primary product is the IzoView breast computed tomography (CT) system, which is designed to generate three-dimensional images of the breast and support the detection and evaluation of breast disease.

Unlike conventional mammography, the IzoView system is designed to image the breast without the same type of compression used in standard mammographic procedures. The company has also explored contrast-enhanced breast CT applications, with the goal of providing additional information for clinicians assessing suspicious findings and other breast conditions.

Izotropic is based in Richmond, British Columbia, Canada, and is focused on product development, clinical validation, regulatory activities and potential commercialization of its imaging technology.